Pharma Journalist - Page 731 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

MeiraGTx receives rare pediatric disease designation for gene therapy A001

Carmot enters a Multi-Year Drug Discovery Collaboration with Amgen

Aerogen & Lyomark Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial

Gilead Sciences and Kite to acquire Cell Design Labs

Roche lymphoma drug drives high remission rate, longer survival

Immuneed shows unique immunomodulating drug-safety evaluation assay and new strategy for therapeutic cancer vaccination

Gilead Sciences and Kite to Acquire Cell Design Labs

Acorda Resubmits New Drug Application for INBRIJA (CVT-301, levodopa inhalation powder)

Neon Therapeutics Announces Clinical Trial Collaboration with Merck

Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain